Boris Gorsh

509 citations
52 papers · 294 indexed · h-index 8
Topics
Multiple Myeloma Research and Treatments (23 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers)Chronic Myeloid Leukemia Treatments (13 papers)

In The Last Decade

Boris Gorsh

46 papers receiving 290 citations

Peers

Boris Gorsh
Comparison fields: 5 of 64
  • Hematology 103
  • Molecular Biology 73
  • Oncology 66
  • Pulmonary and Respiratory Medicine 58
  • Physiology 57
Replace Heidi Segers with:
Heidi Segers Belgium
D. Licu Switzerland
Seung Won Choi South Korea
Fibo Ten Kate Netherlands
Alexandra Paravisini Spain
Pankti Reid United States
Wanda Knopińska‐Posłuszny Poland
Kathryn Ciccolini United States
Gianpaolo Marcacci Italy
Georges Garnier France
Boris Gorsh relative to Heidi Segers Belgium Heidi Segers's profile →
Citations per field
00.5×4.8×
Heidi Segers · 1×
Citations per year

Countries citing papers authored by Boris Gorsh

Since Specialization
Citations

This map shows the geographic impact of Boris Gorsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Gorsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Gorsh more than expected).

Fields of papers citing papers by Boris Gorsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Gorsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Gorsh. The network helps show where Boris Gorsh may publish in the future.

Co-authorship network of co-authors of Boris Gorsh

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Gorsh. A scholar is included among the top collaborators of Boris Gorsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Gorsh. Boris Gorsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 7
4 1
5 3
6 9
7 3
8 8
9 1
10 4
11 1
12 5
13 56
14 2
15 4
16 26
17 2
18 23
19 34
20 2

About Boris Gorsh

Boris Gorsh is a scholar working on Hematology, Genetics and Family Practice, having authored 52 papers that have together received 294 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers) and Chronic Myeloid Leukemia Treatments (13 papers). The work is most often cited by research in Hematology (103 citations), Urology (53 citations) and Dermatology (41 citations). Boris Gorsh has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Vanja Sikirica, Patrick Lefèbvre, Marie‐Hélène Lafeuille, Arash Mostaghimi, Randall Winnette, Jason Xenakis, Samuel H. Zwillich, Lynne Napatalung, Mei Sheng Duh and Jie Zhang. Their work appears in journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026